Biomechanical Characterization and Remodeling of Pulmonary Arteries in Chronic Thromboembolic Pulmonary Hypertension
By: Raysa-Ariana Mesani and Eliza Russu
References
- Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(1). doi: 10.1183/13993003.01915-2018
- Chong C, Tay E, Sia C, Poh K. Chronic thromboembolic pulmonary hypertension: a review. SMEDJ. Published online 2021:318–325. doi: 10.11622/smedj.2021089
- Delcroix M, Torbicki A, Gopalan D, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021;57(6). doi: 10.1183/13993003.02828-2020
- Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2022;43(38):3618–3731. doi: 10.1093/eurheartj/ehac237
- Cannon JE, Jenkins DP, Hoole SP. Chronic thromboembolic pulmonary hypertension: a review of risk factors, management and current challenges. Expert Rev Cardiovasc Ther. 2022;20(1):35–43. doi: 10.1080/14779072.2022.2034499
- Lutsey PL, Evensen LH, Thenappan T, et al. Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database. J Am Heart Assoc. 2022;11(14):e024358. doi: 10.1161/JAHA.121.024358
- Rosen K, Raanani E, Kogan A, et al. Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management. J Heart Lung Transplant. 2022;41(2):208–216. doi: 10.1016/j.healun.2021.10.016
- Arbănași EM, Kaller R, Mureșan AV, Voidăzan S, Arbănași EM, Russu E. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935
- Mureșan AV, Russu E, Arbănași EM, et al. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management-A Single-Center Experience in Romania. J Clin Med. 2022;11(9):2452. doi: 10.3390/jcm11092452
- Halmaciu I, Arbănași EM, Kaller R, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients’ Mortality. Diagnostics. 2022;12(9):9. doi: 10.3390/diagnostics12092089
- Stoian M, Andone A, Boeriu A, et al. COVID-19 and Clostridioides difficile Coinfection Analysis in the Intensive Care Unit. Antibiotics. 2024;13(4):4. doi: 10.3390/antibiotics13040367
- Stoian A, Bajko Z, Stoian M, et al. The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature. Vaccines (Basel). 2023;11(7):1225. doi: 10.3390/vaccines11071225
- Hogea T, Suciu BA, Chinezu L, et al. Pregnancy-Associated Spontaneous Coronary Acute Dissection as a Cause of Sudden Cardiac Death—Autopsy Findings and Literature Review: Is COVID-19 Related? Medicina. 2023;59(7). doi: 10.3390/medicina59071257
- Arbănași EM, Halmaciu I, Kaller R, et al. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(10):10. doi: 10.3390/diagnostics12102379
- Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(11):11. doi: 10.3390/diagnostics12112757
- Jong CMM de, Visser C, Bemelmans RHH, et al. Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism. Eur Respir J. 2023;61(4). doi: 10.1183/13993003.00171-2023
- Cueto-Robledo G, Roldan-Valadez E, Graniel-Palafox LE, et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Review of Another Sequel of Severe Post-Covid-19 Pneumonia. Curr Probl Cardiol. 2023;48(8):101187. doi: 10.1016/j.cpcardiol.2022.101187
- Caguana-Vélez OA, Khilzi K, Piccari L, et al. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2. Respiration. 2024;103(2):79–87. doi: 10.1159/000536064
- Delcroix M, Kerr K, Fedullo P. Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors. Annals ATS. 2016;13(Supplement_3):S201–S206. doi: 10.1513/AnnalsATS.201509-621AS
- Escribano-Subias P, Blanco I, López-Meseguer M, et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J. 2012;40(3):596–603. doi: 10.1183/09031936.00101211
- Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonaryhypertension(CTEPH):resultsfromaninternational prospective registry. Circulation. 2011;124(18):1973–1981. doi: 10.1161/CIRCULATIONAHA.110.015008
- Leber L, Beaudet A, Muller A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulm Circ. 2021;11(1):2045894020977300. doi: 10.1177/2045894020977300
- Simonneau G, Torbicki A, Dorfmüller P, Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Resp Rev. 2017;26(143). doi: 10.1183/16000617.0112-2016
- Otani N, Watanabe R, Tomoe T, Toyoda S, Yasu T, Nakamoto T. Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension. Int J Mol Sci. 2023;24(4). doi: 10.3390/ijms24043979
- Simonneau G, Dorfmüller P, Guignabert C, Mercier O, Humbert M. Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology. Ann Cardiothorac Surg. 2022;11(2):10619–10119. doi: 10.21037/acs-2021-pte-10
- Lang IM, Dorfmüller P, Noordegraaf AV. The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Annals ATS. 2016;13(Supplement_3):S215–S221. doi: 10.1513/AnnalsATS.201509-620AS
- Sharma NK, Kaur S, Goel RK. Exploring the ameliorative role of α7 neuronal nicotinic acetylcholine receptor modulation in epilepsy and associated comorbidities in post-PTZ-kindled mice. Epilepsy & Behavior. 2020;103:106862. doi: 10.1016/j.yebeh.2019.106862
- Shahidi P, Mentzel L, Blazek S, et al. From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach. Rev Cardiovasc Med. 2024;25(11). doi: 10.31083/j.rcm2511402
- Dorfmüller P, Günther S, Ghigna MR, et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014;44(5):1275–1288. doi: 10.1183/09031936.00169113
- Jansa P, Ambrož D, Kuhn M, et al. Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic. Pulm Circ. 2022;12(1):e12038. doi: 10.1002/pul2.12038
- Kandathil A, Chamarthy M. Pulmonary vascular anatomy & anatomical variants. Cardiovasc Diagn Ther. 2018;8(3):20107–20207. doi: 10.21037/cdt.2018.01.04
- Gupta SK, Aggarwal A, Shaw M, et al. Clarifying the anatomy of common arterial trunk: a clinical study of 70 patients. Eur Heart J Cardiovasc Imaging. 2020;21(8):914–922. doi: 10.1093/ehjci/jez255
- Murota M, Yamamoto Y, Satoh K, et al. An analysis of anatomical variations of the left pulmonary artery of the interlobar portion for lung resection by three-dimensional CT pulmonary angiography and thin-section images. Jpn J Radiol. 2020;38(12):1158–1168. doi: 10.1007/s11604-020-01024-1
- Chikkabyrappa S, Mahadevaiah G, Buddhe S, Alsaied T, Tretter J. Common Arterial Trunk: Physiology, Imaging, and Management. Semin Cardiothorac Vasc Anesth. 2019;23(2):225–236. doi: 10.1177/1089253218821382
- Townsley MI. Structure and Composition of Pulmonary Arteries, Capillaries, and Veins. Comprehensive Physiology. 2012;2(1):675–709. doi: 10.1002/j.2040-4603.2012.tb00402.x
- Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1). doi: 10.1183/13993003.01887-2018
- Tuder RM. Pulmonary vascular remodeling in pulmonary hypertension. Cell Tissue Res. 2017;367(3):643–649. doi: 10.1007/s00441-016-2539-y
- Stenmark KR, Frid MG, Graham BB, Tuder RM. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension. Cardiovasc Res. 2018;114(4):551–564. doi: 10.1093/cvr/cvy004
- Dieffenbach PB, Maracle M, Tschumperlin DJ, Fredenburgh LE. Mechanobiological Feedback in Pulmonary Vascular Disease. Front Physiol. 2018;9. doi: 10.3389/fphys.2018.00951
- Jia Z, Wang S, Yan H, et al. Pulmonary Vascular Remodeling in Pulmonary Hypertension. J Pers Med. 2023;13(2). doi: 10.3390/jpm13020366
- Tobal R, Potjewijd J, Empel VPM van, et al. Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity. Front Med. 2021;8. doi: 10.3389/fmed.2021.806899
- Liu F, Haeger CM, Dieffenbach PB, et al. Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertension. JCI Insight. 2016;1(8). doi: 10.1172/jci.insight.86987
- Leopold JA, Maron BA. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Int J Mol Sci. 2016;17(5). doi: 10.3390/ijms17050761
- Singh I, Oliveira RKF, Naeije R, et al. Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension. CHEST. 2019;156(4):724–732. doi: 10.1016/j.chest.2019.04.111
- Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM. Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure. Circulation. 2020;141(8):678–693. doi: 10.1161/CIRCULATIONAHA.116.022362
- Delcroix M, Noordegraaf AV, Fadel E, Lang I, Simonneau G, Naeije R. Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2012;41(1):224–232. doi: 10.1183/09031936.00047712
- Liu J, Yang P, Tian H, et al. Right ventricle remodeling in chronic thromboembolic pulmonary hypertension. J Transl Int Med. 2022;10(2):125–133. doi: 10.2478/jtim-2022-0027
- Avazmohammadi R, Mendiola EA, Li DS, Vanderslice P, Dixon RAF, Sacks MS. Interactions Between Structural Remodeling and Hypertrophy in the Right Ventricle in Response to Pulmonary Arterial Hypertension. J Biomech Eng. 2019;141(091016). doi: 10.1115/1.4044174
- Mendiola EA, da Silva Gonçalves Bos D, Leichter DM, et al. Right Ventricular Architectural Remodeling and Functional Adaptation in Pulmonary Hypertension. Circulation: Heart Failure. 2023;16(2):e009768. doi: 10.1161/CIRCHEARTFAILURE.122.009768
- Ren X, Johns RA, Gao WD. Right heart in pulmonary hypertension: from adaptation to failure. Pulm Circ. 2019;9(3):2045894019845611. doi: 10.1177/2045894019845611
- Avci BK, Basarici I, Akbulut M, et al. Comorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome. Medicina. 2025;61(5). doi: 10.3390/medicina61050827
- Singh S, Kumar P, Yadav SK, Jaffer FA, Reed GL. Recent Pathophysiological Insights Are Advancing the Treatment of Venous Thromboembolism. JACC: Basic to Translational Science. 2025;10(5):689–703. doi: 10.1016/j.jacbts.2024.12.004
- Lang IM, Campean IA, Sadushi-Kolici R, Badr-Eslam R, Gerges C, Skoro-Sajer N. Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension. Clin Chest Med. 2021;42(1):81–90. doi: 10.1016/j.ccm.2020.11.014
- Poch DS, Auger WR. Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes. Heart Fail Rev. 2016;21(3):309–322. doi: 10.1007/s10741-015-9518-3
- Staal DP, Hendriks PM, van Thor MCJ, et al. Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies. Pulm Circ. 2024;14(3):e12419. doi: 10.1002/pul2.12419
- Pengo V, Lensing AWA, Prins MH, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism. N Engl J Med. 2004;350(22):2257–2264. doi: 10.1056/NEJMoa032274
- Ende-Verhaar YM, Cannegieter SC, Noordegraaf AV, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017;49(2). doi: 10.1183/13993003.01792-2016
- Morris TA, Marsh JJ, Chiles PG, et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. 2009;114(9):1929–1936. doi: 10.1182/blood-2009-03-208264
- Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(09):372–376. doi: 10.1160/TH03-02-0067
- Quarck R, Delcroix M. Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension? Eur Respir J. 2014;44(4):842–845. doi: 10.1183/09031936.00120014
- Magoń W, Stępniewski J, Waligóra M, et al. Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Cells. 2022;11(9). doi: 10.3390/cells11091491
- Roger I, Milara J, Montero P, Cortijo J. The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension. Int J Mol Sci. 2021;22(9). doi: 10.3390/ijms22094980
- Xu WJ, Wu Q, He WN, et al. Interleukin-6 and pulmonary hypertension: from physiopathology to therapy. Front Immunol. 2023;14. doi: 10.3389/fimmu.2023.1181987
- Berghausen EM, Feik L, Zierden M, Vantler M, Rosenkranz S. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension. Herz. 2019;44(2):130–137. doi: 10.1007/s00059-019-4795-6
- Giaid A, Yanagisawa M, Langleben D, et al. Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension. N Engl J Med. 1993;328(24):1732–1739. doi: 10.1056/NEJM199306173282402
- Sharma S, Antoniak S. New Insights in the Pathology of Chronic Thromboembolic Pulmonary Hypertension*. JACC: Basic to Translational Science. 2024;9(1):117–119. doi: 10.1016/j.jacbts.2023.11.009
- Bochenek ML, Leidinger C, Rosinus NS, et al. Activated Endothelial TGFß1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1. Circ Res. 2020;126(2):162–181. doi: 10.1161/CIRCRESAHA.119.315259
- Bochenek ML, Saar K, Nazari-Jahantigh M, et al. Endothelial Overexpression of TGF-ß-Induced Protein Impairs Venous Thrombus Resolution. JACC: Basic to Translational Science. 2024;9(1):100–116. doi: 10.1016/j.jacbts.2023.08.005
- Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Dijke PT. TGF-ß-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci. 2017;18(10). doi: 10.3390/ijms18102157
- Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–1464. doi: 10.1016/S0003-4975(03)00828-2
- Cannon JE, Su L, Kiely DG, et al. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy. Circulation. 2016;133(18):1761–1771. doi: 10.1161/CIRCULATIONAHA.115.019470
- Pillalamarri NR, Patnaik SS, Piskin S, Gueldner P, Finol EA. Ex Vivo Regional Mechanical Characterization of Porcine Pulmonary Arteries. Exp Mech. 2021;61(1):285–303. doi: 10.1007/s11340-020-00678-2
- Azadani AN, Chitsaz S, Matthews PB, et al. Regional mechanical properties of human pulmonary root used for the Ross operation. J Heart Valve Dis. 2012;21(4):527–534.
- Rogers NM, Yao M, Sembrat J, et al. Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension. Pulm Circ. 2013;3(4):936–951. doi: 10.1086/674754
- Fata B, Carruthers CA, Gibson G, et al. Regional structural and biomechanical alterations of the ovine main pulmonary artery during postnatal growth. J Biomech Eng. 2013;135(2):021022. doi: 10.1115/1.4023389
- Cabrera MS, Oomens CWJ, Bouten CVC, Bogers AJJC, Hoerstrup SP, Baaijens FPT. Mechanical analysis of ovine and pediatric pulmonary artery for heart valve stent design. J Biomech. 2013;46(12):2075–2081. doi: 10.1016/j.jbiomech.2013.04.020
- Ion AP, Asztalos A, Ciucanu CC, et al. Optimizing Arterial Tissue Thickness Measurement Protocols: Digital Vernier Caliper Versus Digital Thickness Gauge. Methods and Protocols. 2024;7(6). doi: 10.3390/mps7060090
- Ion AP, Asztalos A, Ciucanu CC, et al. Superior Measurement Accuracy of Digital Thickness Gauge Versus Digital Vernier Caliper in Determining Venous Tissue Thickness. Cureus. 2024;16(9):e68442. doi: 10.7759/cureus.68442
- Arbănași EM, Russu E, Arbănași EM, et al. Effect of Ultraviolet Radiation on the Enzymolytic and Biomechanical Profiles of Abdominal Aortic Adventitia Tissue. J Clin Med. 2024;13(2). doi: 10.3390/jcm13020633
- Trâmbițaș C, Cordoș BA, Dorobanțu DC, et al. Application of Adipose Stem Cells in 3D Nerve Guidance Conduit Prevents Muscle Atrophy and Improves Distal Muscle Compliance in a Peripheral Nerve Regeneration Model. Bioengineering. 2024;11(2). doi: 10.3390/bioengineering11020184
- Arbănași EM, Chirilă TV. Preservation of human vascular tissue and the relevance of temperature: a narrative review. Front Bioeng Biotechnol. 2026;13. doi: 10.3389/fbioe.2025.1631214
Language: English
Page range: 52 - 60
Submitted on: Jan 2, 2026
Accepted on: Feb 19, 2026
Published on: Jun 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Raysa-Ariana Mesani, Eliza Russu, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.